New treatment option for Heart Failure (HF)
Official title Effect of the Home-based Digital-assisted Dyadic Tai Chi (HDTC) Training Program Among Sedentary Individuals With HF and Their Caregivers: a Randomized Controlled Trial
ClinicalTrials.gov ID: NCT06876441
What this study is testing
- What it's testing
- The full scale RCT aims to assess the effectiveness of the HDTC training program in improving functional capacity, cardiac function and secondary outcomes among sedentary chronic heart failure (CHF) individuals, while simultaneously reducing care burden and improving other outcomes for their caregivers.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- CHF individuals:
- aged 18 to 75 years
- diagnosed with CHF, regardless of the HF phenotype (HFrEF, HFmrEF, and HFpEF)
- categorized as NYHA class I, II or III
- 6MWD \>150 meters (mild to moderate HF)
You likely can't join if
- HF individuals:
- plan to undergo surgery within the next 6 months
- have severe comorbidities, such as cancer, liver or kidney failure, or diagnosed psychiatric disorders
- plan to be admitted to a nursing home or other care facilities
- regularly practice Tai Chi or engaging in other forms of exercise in the past 3 months (at least 3 times per week, at least 20 minutes of regular...
- currently participate in similar or related studies.
See the full eligibility criteria
- CHF individuals:
- aged 18 to 75 years
- diagnosed with CHF, regardless of the HF phenotype (HFrEF, HFmrEF, and HFpEF)
- categorized as NYHA class I, II or III
- 6MWD \>150 meters (mild to moderate HF)
- stable phase of disease in the past four weeks and capable of independently practice Tai Chi without any musculoskeletal disorders that may impede joint movement
- sit more than 8 h/d in the past month
- own a smartphone
- volunteer to participate and provide informed consent.
- caregivers:
- age ≥18 years old
- primary caregiver at home, who has emotional ties or social obligations with CHF individuals and provides daily care
- able to exercise Tai Chi without help
- volunteer to participate and provide informed consent.
- HF individuals:
- plan to undergo surgery within the next 6 months
- have severe comorbidities, such as cancer, liver or kidney failure, or diagnosed psychiatric disorders
- plan to be admitted to a nursing home or other care facilities
- regularly practice Tai Chi or engaging in other forms of exercise in the past 3 months (at least 3 times per week, at least 20 minutes of regular exercise each time)
- currently participate in similar or related studies.
- caregivers: formal caregivers, such as nurses, will be excluded.
The study team makes the final eligibility decision.
Where it's taking place
- Qingdao, Shandong, China
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Qingdao, Shandong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.